Published February 6, 2021
| Version Version 1
Dataset
Open
RoB 2 details for Cochrane Review '(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus'
Authors/Creators
- 1. Cochrane Metabolic and Endocrine Disorders Group
Description
Systematic review and meta-analysis on to compare the effects of long-term treatment with (ultra-)long-acting insulin analogues to NPH insulin (neutral protamine Hagedorn) or another (ultra-)long-acting insulin analogue in people with type 1 diabetes mellitus.
Details of the Cochrane risk of bias 2 (RoB 2) tool.
Files
Files
(123.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:7dbdcfb395ba4ce6d61610c385e3dec3
|
123.3 kB | Download |
Additional details
Related works
- Is supplement to
- Journal article: 10.1002/14651858.CD013498 (DOI)